Vanguard Group Inc Marker Therapeutics, Inc. Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.24 - $4.58 $374 - $7,153	1,562 Added 0.09%	1,767,853 $477,000
Q3 2022 Nov 14, 2022	SELL	$0.3 - $3.73 $162,300 - $2.02 Million	-541,003 Reduced 23.45%	1,766,291 $651,000
Q1 2022 May 13, 2022	SELL	$0.37 - $1.0 $140,887 - $380,777	-380,777 Reduced 14.17%	2,307,294 $1.02 Million
Q4 2021 Feb 14, 2022	SELL	$0.95 - $1.72 $3,457 - $6,259	-3,639 Reduced 0.14%	2,688,071 $2.55 Million
Q2 2021 Aug 13, 2021	BUY	$1.88 - $3.56 $5.06 Million - $9.58 Million	2,691,710 New	2,691,710 $7.51 Million

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $259M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.